IRVINE, CA, January 30, 2012 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, plans to announce its operating results for the quarter ended December 31, 2011 after the market closes on Thursday, February 2, 2012 and will host a conference call at 5:00 p.m. ET that day to discuss its results.
To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 387244. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the
science of heart valves and hemodynamic monitoring. Driven
by a passion to help patients, the company partners with
clinicians to develop innovative technologies in the areas
of structural heart disease and critical care monitoring
that enable them to save and enhance lives. Additional
company information can be found at
www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.
# # #distribué par | Ce noodl a été diffusé par Edwards Lifesciences Corporation et initialement mise en ligne sur le site http://www.edwards.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-30 16:51:41 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |